RE-BVS – Piemonte Repository

Sfoglia per AUTORE
ORLOV S
Collezione AOU San Luigi di Orbassano

Items : 4

ARCTIC: durvalumab with or without tremelimumab as third-line or later treatment of metastatic non-small-cell lung cancer. in Annals of oncology : official journal of the European Society for Medical Oncology / Ann Oncol. 2020 May;31(5):609-618. doi: 10.1016/j.annonc.2020.02.006. Epub 2020 Feb 20.

2020
AOU San Luigi di Orbassano

McCleod M; Park K; Soo R; Takeda Y; Marquez-Medina D; Novello S; Mandziuk S; Sugawara S; Fischer JR; Orlov S; Reinmuth N; Planchard D; Geater SL; Powell M; May R; Scheuring U; Stockman P; Kowalski D;

Exploratory analysis of front-line therapies in REVEL: a randomised phase 3 study of ramucirumab plus docetaxel versus docetaxel for the treatment of stage IV non-small-cell lung cancer after disease progression on platinum-based therapy. in ESMO open / ESMO Open. 2020 Jan;5(1):e000567. doi: 10.1136/esmoopen-2019-000567.

2020
AOU San Luigi di Orbassano

Lee P; Wolff K; Alexandris E; Oton AB; Zimmermann AH; Orlov SV; Cuyun Carter G; Brustugun OT; Gans S; Kim JH; Kalofonos H; Iglesias Docampo L; Thomas M; Reck M; Gautschi O; Scagliotti GV; Garon EB; Stefaniak VJ; Socinski MA; Pérol M;

Randomized, double-blind, placebo-controlled trial of evofosfamide (Evo) and pemetrexed (Pem) in advanced non-squamous non-small cell lung cancer (n-s NSCLC) in Journal of Clinical Oncology

2016
AOU San Luigi di Orbassano

Csõszi T; Goldman JW; Szilasi M; Von Pawel J; Novello S; Carter CA; Ciuleanu T-E; Del Conte A; Chatta G; Schenker M; Robert F; Orlov S; Zajda K; De Marinis F; Bennett CL; Kroll S; Pearce TE; Belani C;

Docetaxel plus nintedanib versus docetaxel plus placebo in patients with previously treated non-small-cell lung cancer (LUME-Lung 1): a phase 3, double-blind, randomised controlled trial. in The Lancet. Oncology / Lancet Oncol. 2014 Feb;15(2):143-55. doi: 10.1016/S1470-2045(13)70586-2. Epub 2014 Jan 9.

2014
AOU San Luigi di Orbassano

Reck M; Kaiser R; Mellemgaard A; Douillard JY; Orlov S; Krzakowski M; von Pawel J; Gottfried M; Bondarenko I; Liao M; Gann CN; Barrueco J; Gaschler-Markefski B; Novello S;